Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,296 | 26,986 | 46,293 | 63,474 | 112,646 |
| Marketable Securities | 24,890 | 186,803 | 180,750 | 148,703 | 147,619 |
| Receivables | 42,690 | 7,120 | 6,673 | 6,360 | 6,226 |
| Inventories | 40,610 | 17,217 | 12,451 | 15,206 | 16,344 |
| Income taxes - deferred | 32,094 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 2,883 | 2,000 | 0 | 0 |
| TOTAL | $274,036 | $244,405 | $254,380 | $240,031 | $290,784 |
| Non-Current Assets | |||||
| PPE Net | 1,519 | 1,846 | 3,297 | 9,206 | 11,235 |
| Investments And Advances | 0 | 0 | 0 | 17,527 | 33,597 |
| Intangibles | 1,093,732 | 16,844 | 0 | 0 | 0 |
| Other Non-Current Assets | 19,646 | 2,364 | 460 | 460 | 460 |
| TOTAL | $1,114,897 | $21,054 | $3,757 | $27,193 | $45,292 |
| Total Assets | $1,388,933 | $265,459 | $258,137 | $267,224 | $336,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 34,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,301 | 2,629 | 3,515 | 3,732 | 4,553 |
| Accrued Expenses | 80,093 | 22,266 | 20,338 | 28,916 | 25,555 |
| Other current liabilities | 718 | N/A | N/A | N/A | N/A |
| TOTAL | $166,488 | $33,121 | $32,957 | $38,994 | $36,711 |
| Non-Current Liabilities | |||||
| Long Term Debt | 293,905 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 44,376 | 8,226 | 9,104 | 6,346 | 6,603 |
| Other Non-Current Liabilities | 390,968 | 15,396 | 2,033 | 2,438 | 2,787 |
| TOTAL | $762,492 | $59,930 | $52,383 | $47,634 | $54,079 |
| Total Liabilities | $928,980 | $93,051 | $85,340 | $86,628 | $90,790 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,616 | 21,800 | 21,542 | 21,349 | 21,137 |
| Common Shares | 256 | 218 | 215 | 213 | 211 |
| Retained earnings | -330,443 | -466,260 | -456,658 | -439,908 | -362,839 |
| Other shareholders' equity | -3,617 | -3,491 | -3,247 | -4,842 | -7,028 |
| TOTAL | $459,953 | $172,408 | $172,797 | $180,596 | $245,286 |
| Total Liabilities And Equity | $1,388,933 | $265,459 | $258,137 | $267,224 | $336,076 |